US 9629930
Methods and compositions for treating hemophilia B
granted A61KA61K31/7088A61K45/06
Quick answer
US patent 9629930 (Methods and compositions for treating hemophilia B) held by Sangamo Biosciences, Inc. expires Mon Apr 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sangamo Biosciences, Inc.
- Grant date
- Tue Apr 25 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K31/7088, A61K45/06, A61K48/005, A61P